1. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
   Shuji Murakami et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
2. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology
   Rebecca Wellmann et al, 2018, Cancer CrossRef
3. UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis
   Xuewei Chen et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
4. UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival
   Ankan Bandyopadhyay et al, 2021, The Oncologist CrossRef